Foundry Partners, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Foundry Partners, LLC

  • $1.95 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022
SELL
$548.35 - $738.84 $17.8 Million - $23.9 Million
-32,403 Closed
0 $0
Q1 2022

Apr 14, 2022
SELL
$595.12 - $698.43 $425,510 - $499,377
-715 Reduced 2.16%
32,403 $22.6 Million
Q4 2021

Jan 26, 2022
BUY
$543.48 - $670.97 $18 Million - $22.2 Million
33,118 New
33,118 $20.9 Million

Others Institutions Holding REGN

# of Institutions
1,534
Shares Held
83.6M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Foundry Partners, LLC Portfolio

Follow Foundry Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foundry Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Foundry Partners, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email